Philosophy

For most, ageing is accepted as inevitable.


For a select few, it is approached as a biological process

— one that can be meaningfully addressed.


Premium Medical Japan connects those individuals with the most advanced autologous stem cell therapy available today, proprietary method from Japan.

For most, ageing is accepted as inevitable.


For a select few, it is approached as a biological process

— one that can be meaningfully addressed.


Premium Medical Japan connects those individuals with the most advanced autologous stem cell therapy available today, proprietary method from Japan.

For most, ageing is accepted as inevitable.


For a select few, it is approached as a biological process

— one that can be meaningfully addressed.


Premium Medical Japan connects those individuals with the most advanced autologous stem cell therapy available today, proprietary method from Japan.

The Therapy

The Science of Regeneration

The human body is built on an extraordinary capacity

for self-repair. Stem cells are at the centre of that system

— maintaining and regenerating tissue wherever function has declined.

From birth to the age of 60, the body's stem cell population decreases approximately forty-fold.


This is not simply ageing. It is a measurable biological shift — and one that can be addressed.


Today, stem cell therapy extends beyond established blood treatments into cardiac, neurological, and hepatic regeneration.

It has become the foundation of serious longevity medicine.

The Method

The Sugii Method

Not all stem cell therapies are equal.

The difference lies in how cells are cultivated.

CELLASTAR works in collaboration with Dr. Sugii —

Principal Investigator at A*STAR, Singapore —

to apply a proprietary culture method developed to

suppress oxidative stress during cultivation.

A*STAR is a statutory body under the Government

of Singapore, dedicated to advancing scientific and technological research.

The result: approximately 20% greater cultivation efficiency, and cells that retain stronger therapeutic potential —

even when derived from older patients.

All cultivation is conducted under strict xeno-free conditions.

This is Japanese precision, applied at the cellular level.

The Method

The Sugii Method

Not all stem cell therapies are equal.

The difference lies in how cells are cultivated.

CELLASTAR works in collaboration with Dr. Sugii —

Principal Investigator at A*STAR, Singapore —

to apply a proprietary culture method developed to

suppress oxidative stress during cultivation.

A*STAR is a statutory body under the Government

of Singapore, dedicated to advancing scientific and technological research.

The result: approximately 20% greater cultivation efficiency, and cells that retain stronger therapeutic potential —

even when derived from older patients.

All cultivation is conducted under strict xeno-free conditions.

This is Japanese precision, applied at the cellular level.

The Process

A Seamless Journey of Precision

Phase

01

Adipose Tissue

Collection

(10-15 Minutes)

Phase

01

Adipose Tissue

Collection

(10-15 Minutes)

Phase

01

Adipose Tissue

Collection

(10-15 Minutes)

Phase

02

SUGII Method

Cell Cultivation

(Approx. 6 Weeks)

Phase

02

SUGII Method

Cell Cultivation

(Approx. 6 Weeks)

Phase

02

SUGII Method

Cell Cultivation

(Approx. 6 Weeks)

Phase

03

Treatment

Infusion

(3 Monthly Sessions)

Phase

03

Treatment

Infusion

(3 Monthly Sessions)

Phase

03

Treatment

Infusion

(3 Monthly Sessions)

Access & Discretion

This programme is offered exclusively through private banking

and family office relationships.


All enquiries are handled with absolute discretion.

No information is shared beyond what is necessary for your care. 

About Us

Premium Medical Japan

Premium Medical Japan Co., Ltd. serves as the exclusive liaison for international private clients seeking access to advanced autologous stem cell therapy in Japan.

We work with a carefully selected network of trusted advisors and institutions — ensuring that every client receives not only a world-class clinical pathway, but the discretion and continuity they have come to expect.

Our Partner - Cellastar

Cellastar is the Japanese biotechnology company responsible for the cultivation of autologous stem cells used in this programme.

Operating under strict quality standards, Cellastar applies the proprietary Sugii Method to deliver cells of the highest therapeutic potential.

We'd be glad to hear from you

We'd be glad to hear from you

All enquiries are handled in complete confidence.

Get in Touch

Get in Touch

Premium Medical Japan Co., Ltd.

Representative Director:

Sumiko Mita

Unit 2A,17F Glenealy Tower

No.1 Glenealy, Central

Hong Kong

premiummedicaljapan@gmail.com

©2026 Premium Medical Japan Co., Ltd.

Privacy Policy

Premium Medical Japan Co., Ltd.

Representative Director:

Sumiko Mita

Unit 2A,17F Glenealy Tower

No.1 Glenealy, Central

Hong Kong

premiummedicaljapan@gmail.com

©2026 Premium Medical Japan Co., Ltd.

Privacy Policy

Premium Medical Japan Co., Ltd.

Representative Director:

Sumiko Mita

Unit 2A,17F Glenealy Tower

No.1 Glenealy, Central

Hong Kong

premiummedicaljapan@gmail.com

©2026 Premium Medical Japan Co., Ltd.

Privacy Policy